GlassScriptPhysician profile
Lauren D Plass
NPI 1750795910
$2,534.29
in general payments reported to CMS, 2019-2025
15 companies · $608 in 2025
The $608 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $346 · 2021: $94.69 · 2022: $284 · 2023: $392 · 2024: $543 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,542.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $626.34 | 2019-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $316.24 | 2020-2023 | |
| Allergan, INC. | $249.01 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $217.56 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Menicon America INC | $187.12 | 2019-2020 | |
| Harrow Eye, LLC | $172.40 | 2024-2025 | Vevye |
| Oyster Point Pharma, INC. | $166.50 | 2022-2025 | Tyrvaya, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $139.87 | 2024-2025 | Xdemvy |
| Genzyme Corporation | $118.08 | 2021-2025 | |
| Alcon Vision LLC | $103.63 | 2019-2025 | Rocklatan, Tryptyr |
| Dompe US, INC. | $85.60 | 2021-2025 | Oxervate |
| Visioneering Technologies, INC. | $48.00 | 2019-2020 | |
| Rxsight INC | $45.45 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Shire North American Group INC | $39.22 | 2019 | |
| Sight Sciences, INC. | $19.27 | 2023 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Plass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.